- Previous Close
13.38 - Open
13.35 - Bid 13.41 x 40000
- Ask 13.68 x 40000
- Day's Range
13.35 - 13.38 - 52 Week Range
10.77 - 14.50 - Volume
554 - Avg. Volume
30,306 - Market Cap (intraday)
6.992B - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
36.97 - EPS (TTM)
0.37 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield 0.26 (1.89%)
- Ex-Dividend Date Apr 22, 2025
- 1y Target Est
13.80
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
www.convatecgroup.com10,489
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: CNVVY
View MorePerformance Overview: CNVVY
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNVVY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNVVY
View MoreValuation Measures
Market Cap
6.82B
Enterprise Value
7.95B
Trailing P/E
36.77
Forward P/E
20.08
PEG Ratio (5yr expected)
1.78
Price/Sales (ttm)
3.07
Price/Book (mrq)
4.14
Enterprise Value/Revenue
3.47
Enterprise Value/EBITDA
14.72
Financial Highlights
Profitability and Income Statement
Profit Margin
8.32%
Return on Assets (ttm)
6.06%
Return on Equity (ttm)
11.27%
Revenue (ttm)
2.29B
Net Income Avi to Common (ttm)
190.5M
Diluted EPS (ttm)
0.37
Balance Sheet and Cash Flow
Total Cash (mrq)
65.1M
Total Debt/Equity (mrq)
71.18%
Levered Free Cash Flow (ttm)
309.75M